
Inspiring & original thinking. And, the latest news about us.
THINKING
Welcome to Well Filtered™
A blog series dedicated to unearthing the ideas, perspectives, and innovations that matter most in kidney health.
NEWS
- RenalytixAI Announces Launch of Global Offering and Application to List on the Nasdaq Global Market 07.13.20
- RenalytixAI Announces Partnership with America’s Choice Provider Network for Coverage Expansion 07.08.20
- RenalytixAI Announces KidneyIntelX Validation Study Accepted for Publication in American Society of Nephrology Journal Kidney360 07.01.20
- RenalytixAI Announces Partnership with the University of Michigan to Extend KidneyIntelX™ Use to Broad CKD Populations and Data Sharing Agreement with a Top Ten Global Pharmaceutical Company 06.30.20
- RenalytixAI Announces Public Filing of Registration Statement with SEC for a Proposed Nasdaq Dual-listing and Global Offering 06.25.20
- KidneyIntelX™ Receives New York State Approval to Commence Commercial Testing 06.12.20
- Renalytix AI Announces Proposed Dual-listing on Nasdaq 05.18.20
- RenalytixAI Utah Commercial Laboratory Facility Achieves ISO 13485 Certification 04.27.20
- KidneyIntelX™ to Predict Major Adverse Kidney Events in COVID-19 Patients 04.20.20
- RenalytixAI Announces Podium Presentation and Publication on “Evaluation of Payer Budget Impact Associated with the Use of Artificial Intelligence in vitro Diagnostic, KidneyIntelX™, to Modify DKD Progression” 03.24.20